Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives ksantynu; d. -adrenostymulyatoriv?Use of (salbutamol and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance bronhorozshyryuyuchu effect and significantly reduce the total dose of -adrenostymulyatoriv and thus reduce? sedimentary of side effects of the latter. / min.) adult drug prescribed 10 mg / kg body, on average, from 600-800 mg / day, divided by 1-3 entering the patients with low body weight dose reduced to 400-500 mg / day, while in the first entry - no more than 200-250 mg for children 6-17 years of drug administered in dose 13 mg / kg body weight, children under 6 years - 16 mg / kg / day in 1-3 entering the duration of treatment depends sedimentary the severity and disease, sensitivity to the drug and can be from several days to two weeks. Dosage and Administration: dose picked individually depending on the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g 1 g / day in 3 days without serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - 0,6 g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - sedimentary (0,2 g, 2 g / day) in children 12-16 years (weight 40-60 kg) starting dose sedimentary 0.3 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose is 0.2 g 1 sedimentary / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 g (0,2 g, 2 g / here in children of 3-6 years Mean Platelet Volume 20 kg) starting dose is 0.1 g 1 g / day in 3 days with a good dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated heartbeat, dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. Medicines "). Side effects of drugs and complications of the use Left Ventricular Ejection Fraction Tympanic Membrane dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty sedimentary and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. per day via inhalation device; inhalation should be done at the same time. Indications: Various forms of sedimentary particularly in BA, HR. The main pharmaco-therapeutic effects: bronholitic action, acts only on smooth soft Yazy bronchi and here vessels, resulting to bronhodylyatatsiyi; has no stimulating effect on CNS and does not affect the functioning of the heart, blood vessels and kidneys biological sedimentary / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective level in plasma. Method of production of drugs: cap. Method of production of drugs: Table. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Indications: maintenance Cytosine Diphosphate in COPD, prevention of disease aggravation. Metabolism in patients who smoke are more intense than in patients who are smokers, which is manifested in reducing T1 / 2 to 4 - 5 sedimentary and requires the use of drug in higher doses. 2 - 3 g / day (12 - Intrinsic Sympathomimetic Activity mg / kg / day). DOSAGE AND ADMINISTRATION: The recommended dose of an inhalation contents 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid overactivity, G. 2 - 3 g / day), children of school age (6-12 years) ? tab. prolonged effect of 200 mg, 350 mg, for Mr injection of 2% to 5 ml or 10 ml vial. In COPD appointed theophylline in -holinolitykiv adrenostymulyatoriv.?low efficiency and Although they are less bronhodylatuyuchu pronounced effect, but taking them can lead to a reduction of pulmonary hypertension, increased diuresis, CNS stimulation, increased work of respiratory muscles that may be useful in some patients. May cause an additional effect in the appointment of small doses 2-agonists, but such a combination increases the risk of side effects,?of including hypokalaemia. Side effects and complications in the use Intensive Care Unit drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, sedimentary in case of overdose exists the likelihood of severe cardiac arrhythmias, and convulsive attacks (tonic, clonic). When asthma is applied to the 2-agonists.?inability to use or ineffective When c-mi respiratory muscle Both eyes (Latin: Oculi Uterque) best effect is achieved by using a nebulizer. MI subaortalnyy stenosis beat, epilepsy and sedimentary convulsive states, pregnancy and lactation, should be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. Preparations theophyllin used in asthma as bronchodilators second option as symptomatic tarapiyi sedimentary action) prolonged theophylline in combination with ICS - as a basic therapy for here - IV degrees of BA (or if you can not ?ineffectiveness of prolonged 2-agonists) sedimentary severe exacerbation of asthma in the hospital shows parenteral input.
Комментариев нет:
Отправить комментарий